Scleroderma is a chronic autoimmune condition characterized by inflammation and abnormal connective tissue changes that can affect the skin, joints, blood vessels, and internal organs. The course of scleroderma…
Scleroderma is a chronic autoimmune condition characterized by inflammation and abnormal connective tissue changes that can affect the skin, joints, blood vessels, and internal organs. The course of scleroderma varies widely, ranging from localized skin involvement to more systemic disease affecting multiple organ systems. Symptoms often develop gradually and may change over time.
Because scleroderma can affect different parts of the body in different ways, early recognition and comprehensive rheumatologic care are important for long-term management and monitoring.
Scleroderma is an autoimmune connective tissue disease in which the immune system triggers inflammation and excessive collagen production. This can lead to thickening and tightening of the skin and, in some cases, involvement of internal organs such as the lungs, gastrointestinal tract, heart, or kidneys.
The condition is inflammatory and systemic rather than degenerative, and disease severity can vary significantly among individuals.
Symptoms of scleroderma may include:
Not all individuals experience the same symptoms or degree of involvement.
The exact cause of scleroderma is not fully understood, but contributing factors may include:
These factors may interact to influence disease development and progression.
Diagnosis involves a comprehensive evaluation that may include:
Because symptoms can overlap with other connective tissue diseases, careful assessment is important.
Treatment is individualized and may include:
Management strategies are adjusted based on disease manifestations.
A rheumatology evaluation may be appropriate if you experience:
Specialized care is essential for diagnosis and long-term monitoring.
Our approach emphasizes personalized care, careful monitoring, and coordination with other specialists when needed. Treatment plans are designed to address individual symptoms while supporting long-term health.
For patients requiring advanced or infusion-based therapies, these options are provided as part of comprehensive rheumatologic care.
If you are experiencing symptoms suggestive of scleroderma, scheduling a consultation allows for thorough evaluation and discussion of appropriate management options.